MedPath

Effectiveness Study of Community-Based, Peer-Led Education on Weight Loss and Diabetes

Not Applicable
Completed
Conditions
Pre-diabetes
Registration Number
NCT01004848
Lead Sponsor
Icahn School of Medicine at Mount Sinai
Brief Summary

The purpose of this study is to compare the effectiveness of a peer-led community-based lifestyle intervention, versus usual care, in achieving weight loss and prevention of diabetes among overweight adults with pre-diabetes in East Harlem.

Detailed Description

Weight loss can prevent diabetes and eliminate racial and ethnic disparities in incident diabetes among overweight adults with pre-diabetes. However, proven effective interventions have not been sustained or disseminated in community settings. A community-academic partnership aims to employ community-based participatory research to conduct a randomized controlled trial to test the effectiveness of a culturally tailored, peer-led diabetes prevention intervention that promotes weight loss.

People who develop diabetes go through a period when they have "pre-diabetes". In clinical settings, overweight adults with pre-diabetes who reduce their weight by 5-10% can reduce their risk of developing diabetes by 55-60%. To date, there are no studies testing the effectiveness of peer-led, community-based programs in achieving diabetes prevention through weight loss.

We will identify and enroll 400 overweight (BMI \> 25) adults with pre-diabetes in East Harlem and randomized half into a community-based, peer-led lifestyle education program that teaches simple ways to lose weight.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
402
Inclusion Criteria
  • 18 years of age and older
  • Residents of East Harlem or members of an East Harlem Institution in zip codes 10029, 10035, OR in the section of 10037 east of Fifth Avenue
  • BMI ≥ 25 AND pre-diabetes glucose values, defined as fasting fingerstick glucose of 100-125mg/dl and/or glucose 2 hours after an oral glucose load of 140-199 mg/dl
  • Able to communicate verbally to participate in a group education class
  • English or Spanish speaking
Exclusion Criteria
  • < 18 years
  • Previous diagnosis of diabetes
  • BMI <25
  • Fingerstick glucoses outside pre-diabetes level ranges
  • Currently pregnant
  • On medications that may raise or lower blood glucose
  • Cognitive or physical impairment that would preclude comprehension of a conversation and communicating as part of a group (i.e., dementia, deafness, inability to speak)
  • Self-reported terminal illness with life expectancy of less than 1 year
  • Plans to relocate from New York City within one year of enrollment

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Change in Weight From Baseline to 6 MonthsChange from Baseline to 6 Months
Secondary Outcome Measures
NameTimeMethod
HDL CholesterolChange from Baseline to 6 Months
Total CholesterolChange from Baseline to 6 Months
Change in Fasting Fingerstick Glucose Measurement From Baseline to 6 MonthsChange from Baseline to 6 Months

Change in sugar level as measured from fingerstick, at 6 Months as compared to Baseline

Change in Systolic Blood Pressure From Baseline to 6 MonthsChange from Baseline to 6 Months
Change in Diastolic Blood Pressure From Baseline to 6 MonthsChange from Baseline to 6 Months
Waist CircumferenceChange from Baseline to 6 Months
TriglyceridesChange from Baseline to 6 Months
Physical Activity (Self-report)6 months
Change in Post-prandial Fingerstick Glucose From Baseline to 6 MonthsChange in 6 Months from Baseline

Change in sugar level as measured from fingerstick after a meal, at 6 Months as compared to Baseline

LDL CholesterolChange from Baseline to 6 Months
HbA1cChange from Baseline to 6 Months
Energy ExpenditureChange from Baseline to 6 Months

percent energy expenditure

Knowledge & Attitudes About Diabetes Risk6 months
Fiber IntakeChange from Baseline to 6 Months

Trial Locations

Locations (1)

Icahn School of Medicine at Mount Sinai

🇺🇸

New York, New York, United States

Icahn School of Medicine at Mount Sinai
🇺🇸New York, New York, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.